(210) | Number of the EPO application | 18876779 |
(220) | Filing date of the EPO application | 2018.11.11 |
(80) | EPO patent specification publication (B) | EPB nr. 42/2024, 2024.10.16 |
(110) | EPO patent number | 3706739 |
(11) | Number of the document | MD 3706739 T2 |
(21) | Number of the application | e 2020 0953 |
(71) | Name(s) of applicant(s), code of the country | BIOHAVEN THERAPEUTICS LTD., US; |
(72) | Name(s) of inventor(s), code of the country | CORIC Vladimir, US; BERMAN Robert, US; BEINER Melissa, US; L'ITALIEN Gilbert, US; |
(73) | Name(s) of owner(s), code of the country | BIOHAVEN THERAPEUTICS LTD., US; |
(54) | Title of the invention | Use of riluzole prodrugs to treat ataxias |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | A61K 31/428 (2006.01.01); A61K 31/427 (2006.01.01); A61K 31/4985 (2006.01.01); A61P 35/00 (2006.01.01); C07D 277/82 (2006.01.01); C07D 417/12 (2006.01.01); A61K 9/48 (2006.01.01); A61K 9/20 (2006.01.01); A61P 25/14 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2020.10.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2025.02.28 |
(30) | Priority | 201762584856 P, 2017.11.12, US; 201862717948 P, 2018.08.13, US |
(74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
(86) | International application | PCT/US2018/060232, 2018.11.11 |
(87) | International publication | WO 2019/094851, 2019.05.16 |